# Okyo Pharma (stock symbol: OKYO) Logo in transparent PNG format

## Okyo Pharma Logo large

### Okyo Pharma Logo large Download PNG (32.91 KB)

![Okyo Pharma Logo large Download PNG (32.91 KB)](/img/orig/OKYO_BIG-baef385c.png)

## Okyo Pharma Logo icon format

### Okyo Pharma Logo icon format Download PNG (13.25 KB)

![Okyo Pharma Logo icon format Download PNG (13.25 KB)](/img/orig/OKYO-dd42a4d7.png)

## About Okyo Pharma

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

1. Website domain: okyopharma.com
2. Employees: 7
3. Marketcap: $27.43 Million USD


## Categories
- [x] ðŸ‡¬ðŸ‡§ United Kingdom
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
